If you suspect you have this condition, it should be immediately checked. While you can treat ocular hypertension and effectively bring down eye pressure, there is no cure for this condition.

Glaucoma, the leading cause of blindness, is often marked by loss of retinal ganglion cells (RGCs). Necroptosis, a form of ...

Bimatoprost is under clinical development by Laboratoires Thea and currently in Phase III for Ocular Hypertension.

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Design: Prospective, randomized crossover treatment trial. Patients and Methods: Thirty patients newly diagnosed with glaucoma or ocular hypertension requiring intraocular pressure (IOP ...

Topical medications remain the cornerstone of treatment for ocular diseases including infections, uveitic diseases, ocular hypertension and glaucoma, among others. Patients are often exposed to a ...

10, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix ... currently in a Phase 2 clinical trial for the treatment of open-angle glaucoma or ocular hypertension. Follow the Company on its website ...